Evergreen Capital Management LLC Has $412,000 Stock Holdings in Colgate-Palmolive Company $CL

Evergreen Capital Management LLC lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 76.3% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 4,398 shares of the company’s stock after buying an additional 1,903 shares during the quarter. Evergreen Capital Management LLC’s holdings in Colgate-Palmolive were worth $412,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Westend Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 140 shares during the last quarter. Cornerstone Planning Group LLC raised its stake in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after purchasing an additional 287 shares in the last quarter. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $31,000. Y.D. More Investments Ltd acquired a new stake in Colgate-Palmolive in the 1st quarter worth about $37,000. Finally, Bernard Wealth Management Corp. acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $36,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $84.04 on Tuesday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.30. The firm has a market cap of $67.92 billion, a P/E ratio of 23.61, a P/E/G ratio of 4.37 and a beta of 0.35. The company’s 50-day moving average price is $87.06 and its two-hundred day moving average price is $89.84.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 EPS. On average, analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Barclays lifted their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 15th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 7th. Finally, UBS Group decreased their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Seven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $98.92.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.